vs
BRC Inc.(BRCC)与RIGEL PHARMACEUTICALS INC(RIGL)财务数据对比。点击上方公司名可切换其他公司
BRC Inc.的季度营收约是RIGEL PHARMACEUTICALS INC的1.6倍($112.7M vs $69.8M),RIGEL PHARMACEUTICALS INC净利率更高(384.0% vs -2.8%,领先386.9%),RIGEL PHARMACEUTICALS INC同比增速更快(21.2% vs 6.5%),过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高(53.7% vs 7.0%)
BRC Inc.是一家美国高端咖啡与生活方式品牌,主营烘焙咖啡豆、即饮咖啡饮品、品牌服饰及户外装备,核心客群包含退伍军人、急救人员与户外爱好者,在北美地区通过电商及线下实体门店渠道销售产品。
Rigel制药是一家临床阶段生物技术企业,专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法,核心市场位于美国,旗下已获批产品可治疗成人免疫性血小板减少症,致力于满足未被覆盖的临床医疗需求。
BRCC vs RIGL — 直观对比
营收规模更大
BRCC
是对方的1.6倍
$69.8M
营收增速更快
RIGL
高出14.7%
6.5%
净利率更高
RIGL
高出386.9%
-2.8%
两年增速更快
RIGL
近两年复合增速
7.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $112.7M | $69.8M |
| 净利润 | $-3.2M | $268.1M |
| 毛利率 | 32.1% | 91.5% |
| 营业利润率 | -6.3% | 33.2% |
| 净利率 | -2.8% | 384.0% |
| 营收同比 | 6.5% | 21.2% |
| 净利润同比 | -29.3% | 1769.2% |
| 每股收益(稀释后) | $-0.02 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
BRCC
RIGL
| Q4 25 | $112.7M | $69.8M | ||
| Q3 25 | $100.7M | $69.5M | ||
| Q2 25 | $94.8M | $101.7M | ||
| Q1 25 | $90.0M | $53.3M | ||
| Q4 24 | $105.9M | $57.6M | ||
| Q3 24 | $98.2M | $55.3M | ||
| Q2 24 | $89.0M | $36.8M | ||
| Q1 24 | $98.4M | $29.5M |
净利润
BRCC
RIGL
| Q4 25 | $-3.2M | $268.1M | ||
| Q3 25 | $-486.0K | $27.9M | ||
| Q2 25 | $-5.3M | $59.6M | ||
| Q1 25 | $-2.9M | $11.4M | ||
| Q4 24 | $-2.5M | $14.3M | ||
| Q3 24 | $-535.0K | $12.4M | ||
| Q2 24 | $-482.0K | $-1.0M | ||
| Q1 24 | $548.0K | $-8.2M |
毛利率
BRCC
RIGL
| Q4 25 | 32.1% | 91.5% | ||
| Q3 25 | 36.9% | 93.2% | ||
| Q2 25 | 33.9% | 95.6% | ||
| Q1 25 | 36.1% | 91.7% | ||
| Q4 24 | 38.1% | 89.9% | ||
| Q3 24 | 42.1% | 85.5% | ||
| Q2 24 | 41.9% | 92.4% | ||
| Q1 24 | 42.9% | 93.1% |
营业利润率
BRCC
RIGL
| Q4 25 | -6.3% | 33.2% | ||
| Q3 25 | 0.5% | 40.9% | ||
| Q2 25 | -13.3% | 60.1% | ||
| Q1 25 | -6.0% | 23.9% | ||
| Q4 24 | -2.1% | 28.9% | ||
| Q3 24 | 1.1% | 25.4% | ||
| Q2 24 | 1.1% | 1.2% | ||
| Q1 24 | 4.0% | -23.6% |
净利率
BRCC
RIGL
| Q4 25 | -2.8% | 384.0% | ||
| Q3 25 | -0.5% | 40.2% | ||
| Q2 25 | -5.6% | 58.6% | ||
| Q1 25 | -3.2% | 21.5% | ||
| Q4 24 | -2.3% | 24.9% | ||
| Q3 24 | -0.5% | 22.5% | ||
| Q2 24 | -0.5% | -2.8% | ||
| Q1 24 | 0.6% | -27.9% |
每股收益(稀释后)
BRCC
RIGL
| Q4 25 | $-0.02 | $14.11 | ||
| Q3 25 | $0.00 | $1.46 | ||
| Q2 25 | $-0.07 | $3.28 | ||
| Q1 25 | $-0.04 | $0.63 | ||
| Q4 24 | $-0.03 | $0.82 | ||
| Q3 24 | $-0.01 | $0.70 | ||
| Q2 24 | $-0.01 | $-0.06 | ||
| Q1 24 | $0.01 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $4.3M | $155.0M |
| 总债务越低越好 | $34.7M | $52.5M |
| 股东权益账面价值 | $45.7M | $391.5M |
| 总资产 | $209.2M | $513.6M |
| 负债/权益比越低杠杆越低 | 0.76× | 0.13× |
8季度趋势,按日历期对齐
现金及短期投资
BRCC
RIGL
| Q4 25 | $4.3M | $155.0M | ||
| Q3 25 | $9.5M | $137.1M | ||
| Q2 25 | $4.3M | $108.4M | ||
| Q1 25 | $3.9M | $77.1M | ||
| Q4 24 | $6.8M | $77.3M | ||
| Q3 24 | $7.3M | $61.1M | ||
| Q2 24 | $9.6M | $49.1M | ||
| Q1 24 | $4.0M | $49.5M |
总债务
BRCC
RIGL
| Q4 25 | $34.7M | $52.5M | ||
| Q3 25 | $35.0M | $60.0M | ||
| Q2 25 | $72.7M | $60.0M | ||
| Q1 25 | $68.8M | $60.0M | ||
| Q4 24 | $65.1M | $60.0M | ||
| Q3 24 | $64.9M | $60.0M | ||
| Q2 24 | $66.5M | $60.0M | ||
| Q1 24 | $61.5M | $60.0M |
股东权益
BRCC
RIGL
| Q4 25 | $45.7M | $391.5M | ||
| Q3 25 | $48.0M | $117.6M | ||
| Q2 25 | $10.1M | $81.9M | ||
| Q1 25 | $11.2M | $18.6M | ||
| Q4 24 | $13.2M | $3.3M | ||
| Q3 24 | $14.5M | $-14.6M | ||
| Q2 24 | $14.9M | $-29.9M | ||
| Q1 24 | $14.6M | $-31.7M |
总资产
BRCC
RIGL
| Q4 25 | $209.2M | $513.6M | ||
| Q3 25 | $222.4M | $242.5M | ||
| Q2 25 | $225.3M | $206.7M | ||
| Q1 25 | $222.9M | $176.0M | ||
| Q4 24 | $227.4M | $164.0M | ||
| Q3 24 | $233.7M | $139.4M | ||
| Q2 24 | $229.9M | $128.4M | ||
| Q1 24 | $227.2M | $126.5M |
负债/权益比
BRCC
RIGL
| Q4 25 | 0.76× | 0.13× | ||
| Q3 25 | 0.73× | 0.51× | ||
| Q2 25 | 7.19× | 0.73× | ||
| Q1 25 | 6.15× | 3.23× | ||
| Q4 24 | 4.94× | 18.25× | ||
| Q3 24 | 4.47× | — | ||
| Q2 24 | 4.46× | — | ||
| Q1 24 | 4.21× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-8.7M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $-9.4M | — |
| 自由现金流率自由现金流/营收 | -8.3% | — |
| 资本支出强度资本支出/营收 | 0.6% | — |
| 现金转化率经营现金流/净利润 | — | 0.08× |
| 过去12个月自由现金流最近4个季度 | $-13.5M | — |
8季度趋势,按日历期对齐
经营现金流
BRCC
RIGL
| Q4 25 | $-8.7M | $22.0M | ||
| Q3 25 | $6.4M | $24.0M | ||
| Q2 25 | $-3.3M | $30.5M | ||
| Q1 25 | $-4.1M | $-893.0K | ||
| Q4 24 | $2.2M | $14.5M | ||
| Q3 24 | $1.9M | $21.7M | ||
| Q2 24 | $2.3M | $302.0K | ||
| Q1 24 | $4.9M | $-5.0M |
自由现金流
BRCC
RIGL
| Q4 25 | $-9.4M | — | ||
| Q3 25 | $5.6M | — | ||
| Q2 25 | $-4.3M | — | ||
| Q1 25 | $-5.3M | — | ||
| Q4 24 | $504.0K | — | ||
| Q3 24 | $-205.0K | — | ||
| Q2 24 | $147.0K | — | ||
| Q1 24 | $2.2M | — |
自由现金流率
BRCC
RIGL
| Q4 25 | -8.3% | — | ||
| Q3 25 | 5.5% | — | ||
| Q2 25 | -4.5% | — | ||
| Q1 25 | -5.9% | — | ||
| Q4 24 | 0.5% | — | ||
| Q3 24 | -0.2% | — | ||
| Q2 24 | 0.2% | — | ||
| Q1 24 | 2.2% | — |
资本支出强度
BRCC
RIGL
| Q4 25 | 0.6% | — | ||
| Q3 25 | 0.8% | — | ||
| Q2 25 | 1.0% | — | ||
| Q1 25 | 1.3% | — | ||
| Q4 24 | 1.6% | — | ||
| Q3 24 | 2.2% | — | ||
| Q2 24 | 2.4% | — | ||
| Q1 24 | 2.8% | — |
现金转化率
BRCC
RIGL
| Q4 25 | — | 0.08× | ||
| Q3 25 | — | 0.86× | ||
| Q2 25 | — | 0.51× | ||
| Q1 25 | — | -0.08× | ||
| Q4 24 | — | 1.01× | ||
| Q3 24 | — | 1.75× | ||
| Q2 24 | — | — | ||
| Q1 24 | 8.97× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BRCC
| Sales Channel Through Intermediary | $72.9M | 65% |
| Sales Channel Directly To Consumer | $34.4M | 31% |
| Outpost | $5.4M | 5% |
RIGL
暂无分部数据